Clinical Trials Directory

Trials / Completed

CompletedNCT03930914

Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Postural orthostatic tachycardia (POTS) is characterized by abnormalities in the autonomic nervous system in the body. The autonomic nervous system controls and regulates body functions such as heart rate, breathing, digestion, and more. The investigator has shown that patients with POTS have higher cardiovascular and adrenergic activating autoantibodies (AAb), which likely changes the normal make-up of POTS. There are autoantibodies that have been suggested by a few reports of their presence in POTS, but their role different aspects of POTS is unknown. The study will look at the body's responses in patients with POTS. The crossover study design is to have half of the patients will start with sham followed by active stimulation and half will start by active followed by sham stimulation. It is anticipated that results will provide a potential therapeutic approach based on the understanding of POTS.

Conditions

Interventions

TypeNameDescription
DEVICEParasym (TM) Transcutaneous Electrical Nerve Stimulation (TENS) DeviceDaily use of Parasym (TM) device on tragus or ear lobe, as assigned treatment arm

Timeline

Start date
2019-11-04
Primary completion
2020-03-02
Completion
2021-12-07
First posted
2019-04-29
Last updated
2023-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03930914. Inclusion in this directory is not an endorsement.